Mead Johnson Signed Strategic Cooperation Agreement with XBIOME

On June 13th, Mead Johnson China signed a strategic cooperation agreement with the microbiome research and development company “XBIOME”. This agreement will deepen cooperation in the areas of AI+ microbiome innovation platform, precise health management solutions, and functional probiotic products. This cooperation is an innovative attempt by Mead Johnson China to further layout in the field of microbiome health management. Microbiome refers to a relatively stable and balanced microbial community in the human body and external environment, such as the gut, skin, and oral microbiome. Front-line scientific exploration has found that the impact of the human microbiome spans the entire life cycle and is related to immunity, brain development, bone health, emotional health, metabolism, and chronic disease management. (Source: foodtalks)

Visit HPA-China’s Information Hub, CLICK HERE